Annales de Biologie Clinique · Oct 1, 2026
Membrane transport of glucose and glucose homeostasis: molecular basis, physiological mechanisms and pathophysiological implications
By Bastard JP, Fellahi S, Antuna-Puente B et al.
Glucose is an essential energy substrate whose cellular utilization largely depends on membrane transport. GLUT (Glucose Transporter) and SGLT (Sodium-Glucose Cotransporter) proteins perform complementary functions in glucose uptake and reabsorption and are therefore central to energy homeostasis. This narrative review summarizes the molecular and physiological basis of glucose transport, the main characteristics of GLUT and SGLT isoforms, and their hormonal and metabolic regulation. Particular attention is given to GLUT4, whose membrane translocation is regulated by insulin and muscle activity, as well as to intestinal and renal SGLT transporters. The pathophysiological consequences of transporter dysfunction are illustrated through several genetic and metabolic disorders, including GLUT1 deficiency, glucose-galactose malabsorption, and type 2 diabetes. The emerging role of glucose transporters in cancer is also discussed. Tumor metabolic reprogramming, characterized by increased glycolysis, HIF-1α activation, and altered GLUT expression, illustrates the metabolic plasticity of cancer cells and the complexity of targeting glucose metabolism therapeutically. Finally, the clinical benefits of SGLT2 inhibitors and the development of experimental strategies targeting specific GLUT isoforms highlight the therapeutic potential of glucose transport systems. A better understanding of tissue-specific regulation, metabolic plasticity, and compensatory mechanisms may contribute to the development of more selective and context-adapted therapeutic strategies.